Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saibal Kar

Showing results (61-70 of 277) with videos related to

Pageof 28
Sort By:
Archives of Internal Medicine|February 18, 2003
Acute myocardial infarction in human immunodeficiency virus-infected patientsShlomo Matetzky, Michelle Domingo, Saibal Kar, et al.
Circulation. Heart Failure|September 13, 2023
Hemodynamic Manifestations of Concomitant Radiation-Induced Tricuspid Regurgitation and Pericardial Constriction Undergoing Transcatheter Tricuspid Valve RepairKatie P Truong, Marcella Calfon Press, Peyman Benharash, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|March 19, 2015
Bivalirudin Versus Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Patients with Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled TrialsUzoma N Ibebuogu, Oluwaseyi Bolorunduro, Smith Giri, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|April 2, 2015
Erratum to: Bivalirudin Versus Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Patients with Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled TrialsUzoma N Ibebuogu, Oluwaseyi Bolorunduro, Smith Giri, et al.
Journal of the American College of Cardiology|March 19, 2013
Quality of life assessment in the randomized PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) trial of patients at risk for stroke with nonvalvular atrial fibrillationOluseun Alli, Shepal Doshi, Saibal Kar, et al.
Current Cardiology Reviews|August 8, 2017
Impact of Pre-existing Kidney Dysfunction on Outcomes Following Transcatheter Aortic Valve ReplacementIkechukwu A Ifedili, Oluwaseyi Bolorunduro, Tamunoinemi Bob-Manuel, et al.
Indian Heart Journal|September 3, 2021
Percutaneous edge-to-edge mitral valve repair for symptomatic high surgical risk patients with significant mitral regurgitation - Short term and one year follow up results from a single center in IndiaSai Satish, Saibal Kar, Ashish Indani, et al.
Journal of the American College of Cardiology|November 4, 2017
Outcomes With Transcatheter Mitral Valve Repair in the United States: An STS/ACC TVT Registry ReportPaul Sorajja, Sreekanth Vemulapalli, Ted Feldman, et al.
Echocardiography (Mount Kisco, N.Y.)|January 29, 2017
Mitral annular motion in patients after transcatheter MitraClip and mitral valve surgeryKentaro Toyama, Florian Rader, Kengo Ayabe, et al.
Journal of the American College of Cardiology|March 3, 2012
The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudyJuan F Viles-Gonzalez, Saibal Kar, Pamela Douglas, et al.
Pageof 28

Showing results (61-70 of 277) with videos related to

Sort By:
Pageof 28
Archives of Internal Medicine|February 18, 2003
Acute myocardial infarction in human immunodeficiency virus-infected patientsShlomo Matetzky, Michelle Domingo, Saibal Kar, et al.
Circulation. Heart Failure|September 13, 2023
Hemodynamic Manifestations of Concomitant Radiation-Induced Tricuspid Regurgitation and Pericardial Constriction Undergoing Transcatheter Tricuspid Valve RepairKatie P Truong, Marcella Calfon Press, Peyman Benharash, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|March 19, 2015
Bivalirudin Versus Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Patients with Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled TrialsUzoma N Ibebuogu, Oluwaseyi Bolorunduro, Smith Giri, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|April 2, 2015
Erratum to: Bivalirudin Versus Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Patients with Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled TrialsUzoma N Ibebuogu, Oluwaseyi Bolorunduro, Smith Giri, et al.
Journal of the American College of Cardiology|March 19, 2013
Quality of life assessment in the randomized PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) trial of patients at risk for stroke with nonvalvular atrial fibrillationOluseun Alli, Shepal Doshi, Saibal Kar, et al.
Current Cardiology Reviews|August 8, 2017
Impact of Pre-existing Kidney Dysfunction on Outcomes Following Transcatheter Aortic Valve ReplacementIkechukwu A Ifedili, Oluwaseyi Bolorunduro, Tamunoinemi Bob-Manuel, et al.
Indian Heart Journal|September 3, 2021
Percutaneous edge-to-edge mitral valve repair for symptomatic high surgical risk patients with significant mitral regurgitation - Short term and one year follow up results from a single center in IndiaSai Satish, Saibal Kar, Ashish Indani, et al.
Journal of the American College of Cardiology|November 4, 2017
Outcomes With Transcatheter Mitral Valve Repair in the United States: An STS/ACC TVT Registry ReportPaul Sorajja, Sreekanth Vemulapalli, Ted Feldman, et al.
Echocardiography (Mount Kisco, N.Y.)|January 29, 2017
Mitral annular motion in patients after transcatheter MitraClip and mitral valve surgeryKentaro Toyama, Florian Rader, Kengo Ayabe, et al.
Journal of the American College of Cardiology|March 3, 2012
The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudyJuan F Viles-Gonzalez, Saibal Kar, Pamela Douglas, et al.
Pageof 28